Reply to C.d. Atkins and a. Avan et Al

Affiliations

Comment

Charles L Loprinzi et al. J Clin Oncol. 2014.

. 2014 Oct 10;32(29):3342-3.

doi: 10.1200/JCO.2014.57.2537. Epub 2014 Aug 18.

No abstract available

Comment on

Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).
Loprinzi CL, Qin R, Dakhil SR, Fehrenbacher L, Flynn KA, Atherton P, Seisler D, Qamar R, Lewis GC, Grothey A. Loprinzi CL, et al. J Clin Oncol. 2014 Apr 1;32(10):997-1005. doi: 10.1200/JCO.2013.52.0536. Epub 2013 Dec 2. J Clin Oncol. 2014. PMID: 24297951 Free PMC article. Clinical Trial.
Calcium/magnesium infusion for oxaliplatin-induced neuropathy: protective or not?
Avan A, Avan A, Giovannetti E, Peters GJ. Avan A, et al. J Clin Oncol. 2014 Oct 10;32(29):3341. doi: 10.1200/JCO.2014.55.1846. Epub 2014 Aug 18. J Clin Oncol. 2014. PMID: 25135990 No abstract available.
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
Atkins CD. Atkins CD. J Clin Oncol. 2014 Oct 10;32(29):3341. doi: 10.1200/JCO.2014.56.5424. Epub 2014 Aug 18. J Clin Oncol. 2014. PMID: 25135996 No abstract available.